The abstract will be published in the peer-reviewed Metabolism: Experimental and Clinical. The presentation will be available on Biomea Fusion's Investor Relations Page under the Events. Please find a ...

While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have ...

SAN CARLOS, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that ...

Arima Genomics, Inc ., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced new data to be presented at the ...

H3N2, a potent influenza A subtype, is driving significant flu outbreaks globally, causing substantial hospitalizations, ...

Biomea Fusion (BMEA) announced that it presented COVALENT-111 study results at the 23rd World Congress on Insulin Resistance, Diabetes & ...

Lytgobi (futibatinib) marks the first medicine launched by Taiho Oncology Europe in the UK (2) For United Kingdom (UK) Trade and Medical Media Only ...

Blinatumomab addition to chemotherapy significantly improves survival and reduces relapse in pediatric B-cell acute ...

In addition, Vera Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 920,716 shares of Class A common stock at the public offering price, less underwriting ...

Candidates preparing for JEE Advanced 2026 can download the official syllabus PDF from jeeadv.ac.in, released by IIT Roorkee.

Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company developing precision medicines that modulate regulatory T cells (Tregs) to restore immune balance, today announced dosing of the ...